Second-line therapy - Globe Thesis

Keyword [Second-line therapy] Result: 1 - 20 \| Page: 1 of 2
1.	Effectiveness Of Erlotinib As The Sennd-line Therapy In Patients With Advanced NSCLC
2.	Advanced Non Small Cell Lung Cancer Maintenance Treatment Prognostic Analysis Of Second-line Therapy
3.	Meta-analysis Of Pemetrexed\Docetaxel And Platinum Doublet Versus Monotherapy As Second-line Treatment For Advanced Non-small-cell Lung Cancer
4.	Study On HIV-1Primary Drug Resistance,Subtype With Viral Tropism Of Drug-naive AIDS Patients And Evaluation Of Therapeutic Efficacy And Secondary Drug Resistance Of Special AIDS Patients In Some Parts Of China
5.	HIV Drug Resistance Surveillance Among Patients Receiving Antiretroviral Therapy
6.	Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
7.	Efficacy Of Erlotinib Versus Chemotherapy In The Second-line Therapy Of Advanced Non-small-cell Lung Cancer:A Meta-Analysis
8.	A Study Of Clinical Prognosis Of AIDS Patients Receiving Second-line Antiretroviral Therapy In Yunnan, China
9.	Survival Influence Factors Of Patients With Advanced Non-small Cell Lung Cancer And Preliminary Analysis Of Drug Efficacy In The Practical Work
10.	Efficacy And Safety Of EGFR Tyrosine Kinase Inhibitor Monotherapy With Docetaxel Monotherapy In Previously Treated Advanced Non-Small-Cell Lung Cancer: A Meta-analysis
11.	Clinical Study Of Irinotecan Or Docetaxel In Second-line Treatment Of Advanced Esophageal Cancer
12.	Outcome Of Molecular Targeted Agents Plus Chemotherapy For Second-line Therapy Of Metastatic Colorectal Cancer: A Meta-analysis Of Randomized Trials
13.	Retrospective Analysis Of Oxaliplatin Combined With S-1(SOX) As Second-line Treatment For Advanced Gastric Cancer
14.	Analysis Of Survival And Prognosis In Patients With BCLC-C Hepatocellular Carcinoma After Sorafenib Failure
15.	Efficacy Of Caspofungin Combined With Trimethoprim/Sulfamethoxazole As First-line Therapy To Treat Non-HIV Patients With Severe Pneumocystis Pneumonia
16.	Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
17.	AP Versus DP Chemotherapy Regimen As Second-line Therapy In EGFR-TKIs Treated Advanced Non-small-cell Lung Cancer Patients With EGFR Mutations
18.	Retrospective Clinical Study Of Nilotinib As A Second-line Therapy In Imatinib Treatment-failure Patients With Chronic Myeloid Leukemia In Chronic Phase
19.	Paclitaxel Or Irinotecan Monotherapy Or Combined With S-1 Second-line Treatment Of Advanced Gastric Cancer Clinical Study
20.	Efficacy And Safety Of Target Drug As Second Line Treatment For Advanced Gastric Cancer : A Meta Analysis
<<First <Prev Next> Last>> Jump to